Funded by REPHRAIN

Covid19 Vaccine Safety

REPHRAIN has a starting critical mass of 31 internationally-leading experts at the Universities of Bristol, Bath, Edinburgh, King’s College London and UCL, as well as 23 founding partners from industry, non-profit, government, law enforcement and regulation and major international research centres.

#ABOUT

ABOUT THE PROJECT

Approved vaccines and related certifications have been released worldwide by governments as a containing measure against the spread of the 2019-nCoV virus and considered a necessary “pass” to regain freedom of movements for individuals.

Our project, Covid-19 Vaccine Safety (COVSAF) funded by REPHRAIN aims to identify and prevent the harms posed by the availability of illicit Covid-19 vaccines, treatments, medical supplies, falsified documentations among others on the net. It will shed new light on the motivation behind these high-risk behaviours, whilst influencing appropriate regulatory measures and more targeted interventions, in order to protect the safety and wellbeing of vulnerable individuals, wider society and government initiatives during a significantly challenging time globally.

#ABOUT
#TEAM

RESEARCH TEAM

Our team comprises experts from disciplines across the humanities, social sciences, forensic and medical sciences with a rather unique combined expertise in criminology; health services research; cybercrime; preventative medicine; psychiatry; psychology; and public health. It benefits of a collaboration with the industry partner Cybersolace. Its conceptualisation and implementation are based upon the considerable experience in internet monitoring research in combination with analytical work undertaken in ISO accredited laboratories facilities to detect harmful content in pharmaceuticals and other products which have been sold online.

Ornella Corazza, PhD, MA, LLM

Project lead

Professor of Addiction Science at the Psychopharmacology, Drug Misuse & Novel Psychoactive Substances Research Unit at the University of Hertfordshire. Her research concerns primary drug and other behavioural addictions in relation to the use of Internet. Results of her work have been presented in over a hundred peer-review publications, books, numerous invited lectures and media appearances. She is the President of the International Society for Emerging Drugs and Editor-in-Chief of the International Journal for Emerging Trends in Drugs, Addictions, and Health

Learn More

Tim McSweeney, PhD

Project Co-Lead

Tim McSweeney is a senior lecturer in forensic psychology at the University of Hertfordshire. Since the late 1990s, he has been involved in and led numerous local, national and international research studies examining the processes and impacts of different criminal justice interventions.

Learn More

Honor Townshend, MSc, PhD. (candidate)

Researcher

Ph.D. Candidate and Visiting Lecturer in Criminology at the University of Hertfordshire with an expertise on qualitative research methods, Image and Performance Enhancing Drugs (IPEDs), gender studies and netnography. She is also a presenter for TV and online Criminology-based work.

Learn More

Valeria Catalani, MSc, PhD. (candidate)

Researcher

Ph.D, candidate working on the analyses and the assessment Novel Psychoactive Substances (NPS) within the Psychopharmacology, Drug Misuse & Novel Psychoactive Substances Research Unit at the University of Hertfordshire. She has a Master’s degree in Chemistry and Pharmaceutical Technologies (Rome, La Sapienza University, 2010) with special interest in New Psychoactive Substances and computational chemistry. Works experience includes Antidoping, Forensic and High Resolution Mass Spectrometry.

Learn More

Mariya Prilutskaya, PhD.

Researcher

Mariya is a research assistant at Semey Medical University (Pavlodar, Kazakhstan), and graduated from Astana Medical University in 2008. She has worked as a psychiatrist for ten years. The sphere of her professional interests is drug addiction. Since 2012, she has focused on the problems of Novel Psychoactive Substances (NPS) in clinical practice. With the research team of the University of Hertfordshire, Mariya Prilutskaya studies the epidemiological and clinical aspects of drug addictions caused by synthetic cannabinoids and cathinones in Kazakhstan. Mariya was a speaker of IV, V and VI International Conferences on Novel Psychoactive Substances in Budapest, Vienna and Maastricht. She is a member of the International Society for the Study of Emergent Drugs and International Society of Substance Use Professionals. She participated in the development of national clinical standards for management of addictions caused by novel psychoactive substances. Her research activities have been supported by CADAP and UNODC.

Learn More

Hani Banayoti

Industry Partner

Hani is a veteran cybersecurity consultant with a history spanning over 20 years in the profession. He worked for household business consulting firms like KPMG, Atos and QinetiQ, as well as UK Government, advising on numerous aspects of cybersecurity such as operations, incident-management, assurance, risk management, industrial-control-systems, and in digital transformation.
Currently, Hani runs his own independent cybersecurity advisory firm, CyberSolace, in London UK. Helping many organisations and covering numerous sectors such as energy, defence, central government, media, technology, telecoms, health, finance, insurance and legal. Often working with upper management tiers or c-suite level stakeholders to help them with cyber-crime borne breaches, or managing emergent cyber risks, or general consulting around optimising security postures as they navigate technology transformation initiatives.

Learn More
#TEAM
#RESOURCES

USEFUL RESOURCES

#RESOURCES

Emerging Drugs in Sport (Hardback)

Olivier Rabin (editor), Ornella Corazza (editor)

Athletes are always aiming to be faster, better, stronger. New techniques to enhance their sporting performance have increasingly been linked to use of novel psychoactive substances (NPS) and other hard-to-detect substances like performance-enhancing drugs. This book offers a timely analysis of the new challenges posed by this phenomenon in the anti-doping community.

The authors present the first comprehensive perspective on the rapidly shifting doping scenario and reflect on use, regulation, policy, and market structure of NPS used in sports. They highlight the challenges with the list of prohibited substances and methods in and out of competition. They also evaluate how methods to detect new drugs present an ongoing battle for doping control as they have to be adapted constantly.

Novel Psychoactive Substances: Policy, Economics and Drug Regulation

In light of the recent emergence of Novel Psychoactive Substances (NPS) on a global scale, this book provides a timely analysis of the social and economic impact of the NPS phenomenon, and of the global policy and regulatory responses to it. It presents the first comprehensive overview of the international regulation, policy and market structure of the NPS phenomenon, offering a guide to inform legislative discussions and demonstrating from a comparative perspective the different approaches used to address the rise of NPS to date. It covers topics such as organized crime, drug markets, clinical evidence on NPS, and different regulatory approaches also in less explored settings such as prisons and sport environments.

Handbook of Novel Psychoactive Substances: What Clinicians Should Know about NPS

Handbook of Novel Psychoactive Substances (NPS) provides a comprehensive overview of the challenges that clinicians face when dealing with NPS and discusses how the profile of patients and their socio-demographic characteristics frame the serious public health concern that NPS pose. It presents various clinical cases, as well as detailed accounts of symptoms, psychopathology, toxicity, and overall clinical management that NPS require. This handbook brings together a unique collection of chapters written by leading experts in the field, who have felt the need to share their knowledge and experience to improve the clinical practice on NPS and the wellbeing of their patients.

#EVENTS

EVENTS

Find out more about some relevant upcoming events over at the International Society for the Study of Emerging Drugs

#EVENTS